Welcome to Scholar Rock

Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. HARNESSING NEW BIOLOGY FOR TARGETING THE MICROENVIRONMENT. Is discovering and developing a new class of biologic therapies, niche modulators, that selectively target dysregulated growth factors in the disease microenvironment, resulting in therapeutic effects specifically at the source of disease. MORE. Original cellular image courtesy of Owen Tamplin, PhD.

OVERVIEW

The web page scholarrock.com currently has an average traffic ranking of zero (the smaller the higher page views). We have inspected ten pages inside the site scholarrock.com and found twenty-two websites associating themselves with scholarrock.com. There is one contacts and locations for scholarrock.com to help you communicate with them. The web page scholarrock.com has been on the internet for six hundred and seventy-one weeks, ten days, fourteen hours, and thirty-four minutes.
Pages Crawled
10
Links to this site
22
Contacts
1
Addresses
1
Online Since
Aug 2012

SCHOLARROCK.COM TRAFFIC

The web page scholarrock.com has seen diverging quantities of traffic until the end of the year.
Traffic for scholarrock.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for scholarrock.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for scholarrock.com

Date Range

All time
This Year
Last Year
Last Month

SCHOLARROCK.COM HISTORY

The web page scholarrock.com was created on August 25, 2012. It will go back on the market on August 25, 2015. It is currently six hundred and seventy-one weeks, ten days, fourteen hours, and thirty-four minutes old.
REGISTERED
August
2012
EXPIRED
August
2015

PERIOD

12
YEARS
10
MONTHS
11
DAYS

LINKS TO DOMAIN

Home - Arch Venture Partners

ARCH Venture Partners - providing venture capital funds for information technology, life sciences, and physical sciences firms. Read what our entrepreneurs are saying about ARCH. Jay Flatley, Executive Chairman. There is no other venture firm like ARCH.

Childrens Hospital Boston Technology and Innovation Development Office TIDO

MTAs, CDAs and Consulting. Licensed Products in Clinical Trials. Licensed Products on the Market. Business Development and Marketing Group. Building a better hepatitis B vaccine for newborns. The post Single-shot protection? Building a better hepatitis B vaccine for newborns.

michaelgilman.net home on the web

These entities pay me in some fashion. This is an actual day job I am Chairman and CEO. They pay me a salary and I hold shares. This is another day job yes, I have two! I am on the Board of Directors and Scientific Advisory Board and receive a cash stipend and hold.

Promedior Novel Therapeutics for Fibrosis

Promedior is a clinical-stage biotechnology company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis is a harmful process that occurs in many diseases, when normal healthy tissue is replaced with scar tissue, compromising function and ultimately leading to organ failure.

WHAT DOES SCHOLARROCK.COM LOOK LIKE?

Desktop Screenshot of scholarrock.com Mobile Screenshot of scholarrock.com Tablet Screenshot of scholarrock.com

CONTACTS

Scholar Rock, LLC

Nagesh Mahanthappa

7 Old Dee Road

Cambridge, Massachusetts, 02138

UNITED STATES

SCHOLARROCK.COM SERVER

Our parsers detected that a single page on scholarrock.com took two hundred and sixty-six milliseconds to download. Our parsers could not find a SSL certificate, so therefore our crawlers consider this site not secure.
Load time
0.266 secs
SSL
NOT SECURE
Internet Protocol
50.63.88.1

NAME SERVERS

ns19.domaincontrol.com
ns20.domaincontrol.com

BROWSER ICON

SERVER OS AND ENCODING

We caught that this website is utilizing the Apache operating system.

HTML TITLE

Welcome to Scholar Rock

DESCRIPTION

Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. Careers at Scholar Rock. HARNESSING NEW BIOLOGY FOR TARGETING THE MICROENVIRONMENT. Is discovering and developing a new class of biologic therapies, niche modulators, that selectively target dysregulated growth factors in the disease microenvironment, resulting in therapeutic effects specifically at the source of disease. MORE. Original cellular image courtesy of Owen Tamplin, PhD.

PARSED CONTENT

The web page scholarrock.com states the following, "HARNESSING NEW BIOLOGY FOR TARGETING THE MICROENVIRONMENT." We saw that the website also said " Is discovering and developing a new class of biologic therapies, niche modulators, that selectively target dysregulated growth factors in the disease microenvironment, resulting in therapeutic effects specifically at the source of disease." It also said " Original cellular image courtesy of Owen Tamplin, PhD."

SEEK SUBSEQUENT WEBSITES

a room for scholarship seeker

Find a scholarship for your study here. SAFE Finance and Administration Specialist. Rabu, 29 Februari 2012 No Comments.

Scholars-83.blogspot.com

net Agen Judi Poker Domino QQ Ceme Online Indonesia xxx. Lirik Lagu Nasyid Retro Orkes Sinar Murni.

East Africa Scholars Professionals Forum

East Africa Scholars and Professionals Forum. This blog site was started by the first cohort from East Africa to benefit from the Commonwealth Distance Learning Scholarships for Masters programmes at the Institute of Education, University of London. The over 20 members made a decision during their study to find a strategy for continued collaboration beyond that period. This blog site, along with other initiatives was borne out of this decision. Saturday, 12 February 2011. AICS has a pool of Associates th.

. WELCOME TO SCHOLARS HOME .

Excellent result in ICSE and ISC Examinations. Both ICSE and ISC 2015 Examinations. Admission open for the academic year 2015-2016. For more details click here. Felicitation Ceremony 2015 to be held on 25-July-2015.